Família Reverse-Cyte® 5%

Multiple blood grouping ABO - human origin · class IV · Until 28/12/2030

Registration no.
80134860273
Process no.
25351646057202052
Status
Until 28/12/2030
Device type
Multiple blood grouping ABO - human origin (TIPAGEM SANGUÍNEA MÚLTIPLA ABO - ORIGEM HUMANA)
Risk class
IV
Registration holder
GRIFOLS BRASIL LTDA CNPJ 02.513.899/0001-71 · 342 registrations
Manufacturer
MEDION GRIFOLS DIAGNOSTICS AG · Switzerland
Published
28/12/2020
Valid until
28/12/2030
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other multiple blood grouping abo - human origin registrations (5 in total, see all)

ProductClass HolderPublishedStatus
Reverse-Cyte 0.8%
80134860269
IV GRIFOLS BRASIL LTDA 25/11/2019 Until 25/11/2029
SERIGRUP DIANA A2
80134860105
IV GRIFOLS BRASIL LTDA 23/04/2007 Until 23/04/2027
SERIGRUP DIANA 4
80134860102
IV GRIFOLS BRASIL LTDA 09/04/2007 Until 09/04/2027
SERIGRUP DIANA A1/B
80134860084
IV GRIFOLS BRASIL LTDA 28/12/2004 Until 28/12/2034